MAR 09, 2016 05:30 PM PST

Can epigenetics make better cancer drugs?

Natural killer cells that can kill and contain viruses and cancerous tumors can be manipulated by epigenetics, a finding that paves the way for developing more effective cancer drugs.
 
Understanding how a new enzyme affects natural killer cells may eventually help make cancer drugs more effective, but scientists don't yet have enough information about their molecular makeup to use them in the laboratory.

“Natural killer cells are very attractive targets for immunotherapy because they are able to kill tumor cells,” says Si-Yi Chen, professor of molecular microbiology and immunology at the Keck School of Medicine at the University of Southern California.

“While scientists all around the world are working on developing new drugs using NK cells, none of the drugs in development focuses on epigenetic regulation of the cells.”

“Our study describes how an epigenetic process involving the enzyme MYSM1 plays a critical role in the development of natural killer cells.”

Epigenetics involve biochemical changes in the body that directly affect DNA, turning some genes on and turning others off. MYSM1 is an enzyme in the body’s immune system that turns genes on and off by modifying proteins called histones embedded in DNA.

For a study published in Proceedings of the National Academy of Sciences, Chen and colleagues used mice to demonstrate that MYSM1 is required for natural killer cells to mature and function properly.

“We found that MYSM1 creates access to proteins that enhance gene transcription and, ultimately, the maturation of natural killer cells themselves,” says Ph.D. student Vijayalakshmi Nandakumar, the study’s first author.

“To date, there are no elaborate reports linking an epigenetic phenomenon to natural killer cell development. More importantly, unlike conventional therapies, NK cell-based therapies have shown to be more effective against metastasis.

“We believe cancer drugs targeting this pathway could be a viable option for future immunotherapies.”

The National Institutes of Health and a Leukemia & Lymphoma Society Specialized Center of Research Award supported the research.

Source: USC

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
DEC 06, 2019
Cell & Molecular Biology
DEC 06, 2019
RNA Polymerases Can Signal to One Another Over Long Genomic Distances
Scientists have taken a close look at transcription in the Escherichia coli bacterium at the level of a single molecule....
DEC 06, 2019
Cancer
DEC 06, 2019
Altered DNA methylation controls genes in cancer
New research published in the journal Genome Biology provide new information on genomic structural variation via DNA methylation and its connection to gene...
DEC 06, 2019
Cell & Molecular Biology
DEC 06, 2019
Scientists Create a New Version of CRISPR - Prime Editing
A new technique enables researchers to target and modify one base pair out of billions, and could correct disease-causing mutations....
DEC 06, 2019
Technology
DEC 06, 2019
Machine-Learning and Epigenetics Drug Discovery
Machine learning is known for detecting patterns seen in complex data—such uniqueness has proven it roles in health and medicine. Now, researchers at...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Don't Like Vegetables? It Could be Genetic
Don’t like eating vegetables? Researchers from the University of Kentucky (UKY) have found that the reason why may be genetic.  Humans carry two...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Linking Genes and Behavior in an Assessment of Personality in Animals
Anyone that's owned dogs knows that they have a personality, and the same is true of mice....
Loading Comments...